Enquiry/Quote
Esomeprazole / Levosulpiride Tablet bulk supplier for pharma manufacturers

Esomeprazole / Levosulpiride Tablet Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 40mg + 75mg

Reference Brands: Nexpro‑L (India / LATAM), Esolev (India/LATAM)

Category: Gastrointestinal Drugs

Levosulpiride + Esomeprazole is used in the treatment of gastroesophageal reflux disease (acid reflux) and Peptic ulcer disease. Levosulpiride + Esomeprazole is a combination of two medicines: Levosulpiride and Esomeprazole.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Esomeprazole (40 mg) and Levosulpiride (75 mg) is a prescription combination medicine formulated to provide comprehensive relief from acid-related gastrointestinal disorders. This combination is primarily used to treat Gastroesophageal Reflux Disease (GERD), peptic ulcers, and associated symptoms such as heartburn, nausea, bloating, and abdominal discomfort.

Esomeprazole, a proton pump inhibitor (PPI), works by blocking the acid-producing pumps in the stomach lining, thereby reducing gastric acid secretion, preventing irritation of the esophagus, and promoting healing of ulcers. Levosulpiride, a prokinetic agent, enhances gastrointestinal motility and accelerates gastric emptying, which helps relieve nausea, vomiting, and bloating caused by delayed digestion.

Together, this combination provides a dual approach: controlling excess stomach acid while improving digestive movement, offering faster and more effective symptom relief. Typically taken under medical supervision, Esomeprazole and Levosulpiride capsules/tablets are recommended to be taken as prescribed by a physician, ensuring safe and targeted management of chronic and acute gastrointestinal disorders.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Esomeprazole / Levosulpiride is a combination medication used to treat gastroesophageal reflux disease (GERD), acidity, heartburn, indigestion, bloating, and nausea. Esomeprazole, a proton pump inhibitor, reduces stomach acid production, while Levosulpiride, a prokinetic agent, enhances gastrointestinal motility and helps prevent nausea and vomiting. This combination provides effective relief from both acid-related irritation and delayed gastric emptying.

It is made from Esomeprazole, which blocks the acid-producing pumps in the stomach lining to reduce gastric acid secretion, and Levosulpiride, a dopamine D2 receptor antagonist that promotes gastric emptying and controls nausea.

Common trade names include Nexpro‑L, Esolev, Esomotil, Levosome, and Esolev‑M.

This combination is manufactured by multiple pharmaceutical companies in India, including Sun Pharma, Torrent Pharmaceuticals, Abbott, Alkem Laboratories, and Cipla, depending on the brand.

The generic name is Esomeprazole Levosulpiride Tablet.

Brand names include Nexpro‑L, Esolev, Esomotil, Levosome, and Esolev‑M.

These tablets are primarily manufactured in India and exported to regions such as Asia, Africa, and Latin America, depending on regulatory approvals and market demand.

Related Products

Bismuth Subsalicylate

Strength:
262 mg, 525 mg

Form: Oral suspension / Tablet

Reference Brands: Pepto-Bismol (USA/LATAM),

View Details
Plecanatide

Strength:
3 mg

Form: Tablets

Reference Brands: Trulance (USA)

View Details
Naldemedine

Strength:
0.2 mg

Form: Tablets

Reference Brands: Symproic (USA/EU)

View Details
Resmetirom

Strength:
80 mg ,100 mg

Form: Tablets

Reference Brands: Rezdiffra (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.